Quality Assurance/Quality Control

Jul 02, 2018
Pharmaceutical Technology
The delivery device and drug form should be considered when choosing a test method for identifying and measuring particulates in inhaled drug products.
Jun 28, 2018
By Pharmaceutical Technology Editors
The new resin used a combination of “jetting” technology and a high-performance Protein A ligand.
Jun 27, 2018
By Pharmaceutical Technology Editors
FDA sent a warning letter to Henan Lihua Pharmaceutical Co. Ltd. after inspectors found the company failed to ensure the accuracy of its data.
Jun 25, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The company’s next-generation ultraperformance liquid chromatography platform is designed to meet the evolving laboratory requirements for chromatographic performance.
Jun 04, 2018
By Pharmaceutical Technology Editors
The company is recalling two lots of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system due to particulate matter on the syringe plunger.
Jun 02, 2018
Pharmaceutical Technology
Dissolution testing remains one of the pharmaceutical industry’s most straightforward, least expensive QC tools. Research is focusing on ways to extend its reach, improve in-vitro and in-vivo correlation, and make real-time release testing a reality.
Jun 02, 2018
Pharmaceutical Technology
This paper analyzes the effectiveness of histogram binning for representing particle-sizing measurements with accuracy and precision.
Jun 01, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The new kit is expected to detect a broad spectrum of pyrogens while offering high reproducibility and sensitivity as well as eliminating the need for live animal testing.
May 30, 2018
By Pharmaceutical Technology Editors
FDA sent a warning letter to Jilin Shulan Synthetic Pharmaceutical Co., Ltd. after an inspection found CGMP violations including a lack of data integrity.
May 30, 2018
By Pharmaceutical Technology Editors
The new draft guidance addresses the premarketing assessment of a drug’s effect on blood pressure.
native1_300x100
lorem ipsum